Plasma endothelin-1 is not increased in overweight/obese hypertensive African women

Blood Pressure

Volumn 14, Issue 5, 2005, Pages 279-283

  Schutte, R ^a   Huisman, H W ^a   Schutte, A E ^a   Malan, N T ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

African women; Cardiovascular function; Endothelin 1

Indexed keywords

ENDOTHELIN 1;

AFRICAN AMERICAN; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR FUNCTION; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HYPERTENSION; IMMUNOREACTIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AFRICA; BLOOD PRESSURE; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; OBESITY; OVERWEIGHT; VASCULAR RESISTANCE;

EID: 28244455056     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050500210724     Document Type: Article

References (24)

1. Walker ARP, Adam F, Walker BF. World pandemic of obesity: The situation in Southern African populations. Public Health. 1997;115:368-372.
2. Kaufman JS, Durazo-Arvizu RA, Rotimi CN, McGee DL, Cooper RS. Obesity and hypertension prevalence in populations of African origin. Epidemiology. 1996;7:398-405.
3. Anon. South African Health Review. Durban: Health Systems Trust; 1998. pp 213-249.
4. Ergul S, Parish DC, Puett D, Ergul A. Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension. Hypertension. 1996;28:652-655.
5. Campia U, Cardillo C, Panza JA. Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Circulation. 2004;109:3191-3195.
6. Parrinello G, Scaglione R, Pinto A, Corrao S, Cecala M, Di Silvestre G, et al. Central obesity and hypertension. The role of plasma endothelin. Am J Hypertens. 1996;9:1186-1191.
7. Cardillo C, Campia U, Iantorno M, Panza JA. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension. 2004;43:36-40.
8. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci. 1988;85: 9797-9800.
9. Guidelines Committee. European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21: 1011-1053.
10. Wesseling KH, Settels JJ, De Wit B. The measurement of continuous finger arterial pressure noninvasively in stationary subjects. In: Schmidt TH, Dembroski TM, Blumchen G, editors. Biological factors in cardiovascular disease. Berlin: Springer; 1986. pp 355-375.
11. Wesseling KH, Jansen JRC, Settles JJ, Schreuder JJ. Computation of aortic flow from pressure in humans using a nonlinear, three-element model. J Appl Physiol. 1993;74:2566-2573.
12. Silke B, McAuley D. Accuracy and precision of blood pressure determination with the Finapres: An overview using re-sampling statistics. J Hum Hypertens. 1998;12: 4093-4096.
13. McAuley D, Silke B, Farrel S. Reliability of blood pressure determination with the Finapres with altered physiological states or pharmacodynamic conditions. Clin Auton Res. 1997;7:179-187.
14. Imholz BPM, Wieling W, van Montfrans GA, Wesseling KH. Fifteen years experience with finger arterial pressure monitoring: Assessment of the technology. Cardiovasc Res. 1998;38: 605-616.
15. Langewouters GJ, Settles JJ, Roelandt R, Wesseling KH. Why use Finapres or Portapres rather than intra-arterial or intermitted non-invasive techniques of blood pressure measurement. J Med Eng Technol. 1998;22:37-43.
16. Harms MP, Wesseling KM, Port F, Jenstrup M, Van Goudoever J, Secher NH, et al. Continuous stroke volume monitoring by modelling flow from non-invasive measurement of arterial pressure in humans under orthostatic stress. Clin Sci. 1999;97:291-301.
17. Schutte AE, Huisman HW, van Rooyen JM, Malan NT, Schutte R. Validation of the Finometer device for measurement of blood pressure in black women. J Hum Hypertens. 2004;18:79-84.
18. Schutte AE, Huisman HW, van Rooyen JM, Oosthuizen W, Jerling JC. Sensitivity of the Finometer device in detecting acute and medium-term changes in cardiovascular function. Blood Press Monit. 2003;8:195-201.
19. Norton K, Olds T. Anthropometrica: A textbook of body measurements for sports and health courses. Sydney: UNSW Press; 1996.
20. Keller G. Applied Statistics with Microsoft® Excel. Australia: Duxbury; 2001.
21. Middlemost SJ. Beyond systolic and diastolic blood pressure. Cardiology. 1999;21:28-35.
22. Van Bortel LM, Spek JJ. Influence of aging on arterial compliance. J Hum Hypertens. 1998;12:583-586.
23. Hickey KA, Rubanyi G, Paul RJ, Highsmith RF. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol. 1985;248: C550-C556.
24. Lüscher T, Barton M. Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs. Circulation. 2000;102:2434-2440.